index - CRCL - PGC - Plateforme de génomique des cancers

Simon Durand, Yaqi Tang, Roxane M Pommier, Valentin Benboubker, Maxime Grimont, et al.. ZEB1 controls a lineage-specific transcriptional program essential for melanoma cell state transitions. Oncogene, In press, ⟨10.1038/s41388-024-03010-7⟩. ⟨hal-04526523⟩
Allison Voisin, Maud Plaschka, Marlène Perrin-Niquet, Julie Twardowski, Insaf Boutemine, et al.. The NF-κB RelA transcription factor is not required for CD8+ T-cell function in acute viral infection and cancer. Frontiers in Immunology, 2024, 15, pp.1379777. ⟨10.3389/fimmu.2024.1379777⟩. ⟨hal-04526553⟩
Armelle Dufresne, Valéry Attignon, Anthony Ferrari, Laurie Tonon, Sandrine Boyault, et al.. Added value of whole‐exome and RNA sequencing in advanced and refractory cancer patients with no molecular‐based treatment recommendation based on a 90‐gene panel. Cancer Medicine, 2024, 13 (7), pp.e7115. ⟨10.1002/cam4.7115⟩. ⟨hal-04646005⟩
Hermes Paraqindes, Nour-El-Houda Mourksi, Samantha Ballesta, Jordan Hedjam, Fleur Bourdelais, et al.. Isocitrate dehydrogenase wt and IDHmut adult-type diffuse gliomas display distinct alterations in ribosome biogenesis and 2’O-methylation of ribosomal RNA. Neuro-Oncology, 2023, ⟨10.1093/neuonc/noad140⟩. ⟨hal-04203242⟩
Ludivine Amable, Luis Antonio Ferreira Martins, Remi Pierre, Marcio Do Cruseiro, Ghita Chabab, et al.. Intrinsic factors and CD1d1 but not CD1d2 expression levels control invariant natural killer T cell subset differentiation. Nature Communications, 2023, 14 (1), pp.7922. ⟨10.1038/s41467-023-43424-7⟩. ⟨hal-04328475⟩
Clara Savary, Léa Luciana, Paul Huchedé, Arthur Tourbez, Claire Coquet, et al.. Fusion-negative rhabdomyosarcoma 3D organoids to predict effective drug combinations: A proof-of-concept on cell death inducers. Cell Reports Medicine, 2023, 4, ⟨10.1016/j.xcrm.2023.101339⟩. ⟨hal-04374201⟩

Derniers manuscrits de la plateforme

Chiffres clés